356 related articles for article (PubMed ID: 15985429)
41. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes.
Kang MI; Kobayashi A; Wakabayashi N; Kim SG; Yamamoto M
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2046-51. PubMed ID: 14764898
[TBL] [Abstract][Full Text] [Related]
42. Effect of combined exposure to environmental aliphatic electrophiles from plants on Keap1/Nrf2 activation and cytotoxicity in HepG2 cells: A model of an electrophile exposome.
Abiko Y; Aoki H; Kumagai Y
Toxicol Appl Pharmacol; 2021 Feb; 413():115392. PubMed ID: 33428920
[TBL] [Abstract][Full Text] [Related]
43. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
[TBL] [Abstract][Full Text] [Related]
44. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications.
Keum YS
Ann N Y Acad Sci; 2011 Jul; 1229():184-9. PubMed ID: 21793854
[TBL] [Abstract][Full Text] [Related]
45. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers.
Satoh T; Okamoto SI; Cui J; Watanabe Y; Furuta K; Suzuki M; Tohyama K; Lipton SA
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):768-73. PubMed ID: 16407140
[TBL] [Abstract][Full Text] [Related]
46. Keap1-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles.
Turpaev KT
Biochemistry (Mosc); 2013 Feb; 78(2):111-26. PubMed ID: 23581983
[TBL] [Abstract][Full Text] [Related]
47. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation.
Kobayashi M; Yamamoto M
Antioxid Redox Signal; 2005; 7(3-4):385-94. PubMed ID: 15706085
[TBL] [Abstract][Full Text] [Related]
48. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
49. Activation of the Kelch-like ECH-associated protein 1 (Keap1)/NF-E2-related factor 2 (Nrf2) pathway through covalent modification of the 2-alkenal group of aliphatic electrophiles in Coriandrum sativum L.
Abiko Y; Mizokawa M; Kumagai Y
J Agric Food Chem; 2014 Nov; 62(45):10936-44. PubMed ID: 25307732
[TBL] [Abstract][Full Text] [Related]
50. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
51. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway.
Yu M; Li H; Liu Q; Liu F; Tang L; Li C; Yuan Y; Zhan Y; Xu W; Li W; Chen H; Ge C; Wang J; Yang X
Cell Signal; 2011 May; 23(5):883-92. PubMed ID: 21262351
[TBL] [Abstract][Full Text] [Related]
52. The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613.
Hourihan JM; Kenna JG; Hayes JD
Antioxid Redox Signal; 2013 Aug; 19(5):465-81. PubMed ID: 23145493
[TBL] [Abstract][Full Text] [Related]
53. Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants.
Dinkova-Kostova AT; Kostov RV; Canning P
Arch Biochem Biophys; 2017 Mar; 617():84-93. PubMed ID: 27497696
[TBL] [Abstract][Full Text] [Related]
54. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm.
Zipper LM; Mulcahy RT
J Biol Chem; 2002 Sep; 277(39):36544-52. PubMed ID: 12145307
[TBL] [Abstract][Full Text] [Related]
55. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1.
Lo SC; Hannink M
Mol Cell Biol; 2006 Feb; 26(4):1235-44. PubMed ID: 16449638
[TBL] [Abstract][Full Text] [Related]
56. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
Itoh K; Mimura J; Yamamoto M
Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
[TBL] [Abstract][Full Text] [Related]
57. Keap1 modification and nuclear accumulation in response to S-nitrosocysteine.
Buckley BJ; Li S; Whorton AR
Free Radic Biol Med; 2008 Feb; 44(4):692-8. PubMed ID: 18062931
[TBL] [Abstract][Full Text] [Related]
58. USP15 negatively regulates Nrf2 through deubiquitination of Keap1.
Villeneuve NF; Tian W; Wu T; Sun Z; Lau A; Chapman E; Fang D; Zhang DD
Mol Cell; 2013 Jul; 51(1):68-79. PubMed ID: 23727018
[TBL] [Abstract][Full Text] [Related]
59. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation.
Fourquet S; Guerois R; Biard D; Toledano MB
J Biol Chem; 2010 Mar; 285(11):8463-71. PubMed ID: 20061377
[TBL] [Abstract][Full Text] [Related]
60. Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole.
Abiko Y; Miura T; Phuc BH; Shinkai Y; Kumagai Y
Toxicol Appl Pharmacol; 2011 Aug; 255(1):32-9. PubMed ID: 21651925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]